Use of linezolid susceptibility test results as a surrogate for the susceptibility of Gram-positive pathogens to tedizolid, a novel oxazolidinone

BACKGROUND: Tedizolid is a novel oxazolidinone antibacterial with potent activity against a wide range of Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. Although tedizolid is approved by the US Food and Drug Administration (FDA) f...

Descripción completa

Detalles Bibliográficos
Autores principales: Zurenko, Gary, Bien, Paul, Bensaci, Mekki, Patel, Hina, Thorne, Grace
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4291835/
https://www.ncbi.nlm.nih.gov/pubmed/25238753
http://dx.doi.org/10.1186/s12941-014-0046-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4291835/
https://www.ncbi.nlm.nih.gov/pubmed/25238753
http://dx.doi.org/10.1186/s12941-014-0046-0

Ejemplares similares